Table 1

Percentage of H-460 cells in late or early apoptosis at the end of treatment period either with doxorubicin or P276-00 alone or in the combination of doxorubicin followed by P276-00
Treatment group Percentage of cells
Live cells Annexin +ve Annexin + PI PI +ve
Control 90.5 3 4 2.3
Doxorubicin ( 100 nM) 60 30.4 8.6 1
P276-00 (1200 nM) 53 38.5 8.2 0.3
Doxorubicin> P276-00 14.1 50.2 34.3 2

Rathos et al.

Rathos et al. BMC Cancer 2013 13:29   doi:10.1186/1471-2407-13-29

Open Data